NeurAxis, Inc. (NRXS) Stock Score, Valuation & Financial Research
NeurAxis, Inc. is in the Healthcare sector and Biotechnology industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 29/100.
Quick answer for NRXS
NeurAxis, Inc. currently has a Wall Street Score of 29/100. The stored market price is $6.94. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What NeurAxis, Inc. does
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
NRXS financial snapshot
- Wall Street Score:
- 29/100
- Current price:
- $6.94
- Market capitalization:
- $86.6M
- Revenue:
- $5.3M
- Net income:
- $-7.9M
- Free cash flow:
- $-6.5M
- Cash:
- $8.3M
- Total debt:
- $279K
- EPS:
- -0.77
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 37/100
What stands out
- Reported year-over-year revenue growth is +0.5%.
- Free cash flow is $-6.5M, showing cash burn in the current stored period.
- The balance sheet shows $8.3M of cash versus $279K of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-08.
How to research NRXS
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.